Scientific Interchange & Workshop


Advances in Risk-Stratification and Therapeutic Options for Early-Stage Non–Small Cell Lung Cancer

October 13th 2021

Updates in the Treatment of Waldenström Macroglobulinemia

August 13th 2021

Molecular Targets on the Horizon in Non–Small Cell Lung Cancer

July 23rd 2021

Updates in the Treatment of Mantle Cell Lymphoma

July 16th 2021

Treatment Considerations in Relapsed Refractory Multiple Myeloma

July 16th 2021

Updates in the Treatment of Diffuse Large B-cell Lymphoma

July 16th 2021

Understanding the Evolving Role of PI3K Inhibitors in the Treatment of Follicular Lymphoma

July 8th 2021

Updates in ALK-Positive Non–Small Cell Lung Cancer

July 8th 2021

Treatment Strategies in HER2+ Gastrointestinal Malignancies

June 21st 2021

OncLive® Scientific Interchange and Workshop Podcast Series: Management of HER2+ Breast Cancer

June 8th 2021

In this 3-part podcast series from a previously recorded event, William Gradishar, MD, is joined by community medical oncologists to discuss the remaining unmet needs in the management of HER2-positive breast cancer, and the treatment of early and advanced stage HER2-positive breast cancer.

OncLive® Scientific Interchange and Workshop Podcast Series: Updates in the Management of HER2+ Breast Cancer

May 27th 2021

In this 3-part podcast series from a previously recorded event, Komal Jhaveri, MD, is joined by community medical oncologists from New York and New Jersey to discuss the remaining unmet needs in the management of HER2-positive breast cancer, and the treatment of early and advanced stage HER2-positive breast cancer.

OncLive® Scientific Interchange and Workshop Podcast Series: Treatment Updates in HER2+ Breast Cancer

May 26th 2021

In this 3-part podcast series from a previously recorded event, Virginia Kaklamani, MD, DSc, is joined by community medical oncologists to discuss the remaining unmet needs in the management of HER2-positive breast cancer, and the treatment of early and advanced stage HER2-positive breast cancer.

A New Therapeutic Target in Non–Small Cell Lung Cancer: HER2

April 23rd 2021

The Evolving Role of Immunotherapy in Metastatic Non–Small Cell Lung Cancer

April 15th 2021

Uncommon EGFR Mutations in Non–Small Cell Lung Cancer

April 15th 2021

New Therapeutic Targets in Non–Small Cell Lung Cancer: KRAS G12C

April 13th 2021